MediQuality Academy

Maximum: 6 CME cr.
Sign in to view your progression
Program Overview Progr...
Target Audience Targe...
Credit Designation Credi...
Disclosure/Disclaimer Discl...

CLINICAL RELEVANCE OF EOSINOPHILS IN GI DISEASES (Accredited 6CP)

This online course, split in 3 separate modules, is based on the recording of a live event that took place on 19/11/2021 in Eindhoven, supported by an unrestricted grant from Dr Falk.

MODULE 1 : Eosinophils in the esophagus

  • Pathophysiology and increasing incidence of EoE - Dr. Marijn Warners (St. Antonius Ziekenhuis, The Netherlands)
  • Medical therapy of EoE - Prof. dr. Arjan Bredenoord (UMC Amsterdam, The Netherlands)
  • Diet and dilatation - Prof. dr. Joris Arts (AZ Sint-Lucas, Belgium)

MODULE 2 : Eosinophils in the stomach and small bowel

  • Is functional dyspepsia an eosinophilic disease? - Dr. Lucas Wauters (KU Leuven, Belgium)
  • Therapy of functional dyspepsia - Dr. Jolien Schol (KU Leuven, Belgium)
  • Eosinophilic gastritis and gastroenteritis - Prof. dr. Tim Vanuytsel (KU Leuven, Belgium)

MODULE 3 : Eosinophils in the colon

  • Eosinophils in IBD: prognostic marker and new therapeutic target? - Dr. Joep Grootjans (Amsterdam UMC, The Netherlands)
  • Diagnosis and therapy of microscopic colitis - Dr. Bram Verstockt (KU Leuven, Belgium)
  • Therapy of IBS - Dr. Daniel Keszthelyi (Maastricht UMC+, The Netherlands)

​​Chair: Prof. dr. T. Vanuytsel (KU Leuven, Belgium) and Prof. dr. A. Bredenoord (UMC Amsterdam, The Netherlands).

These e-learning sessions are available for

  • Gastro-enterologists
  • General practitionners

In order to be eligible for the credit points

  • You must follow all 3 modules of this training
  • And complete all 3 evaluation forms 

Accreditation request approved for Belgium: 6CP (nr 22003501)

MediQuality

  • MediQuality requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest.
  • MediQuality encourages Authors to identify investigational products or off-label uses of products regulated by the European Food and Drug Administration, at first mention and where appropriate in the content.
  • The people working for MediQuality have disclosed that they have no relevant financial relationships.
  • MediQuality is the responsible publisher for this e-learning.
ACCREDITED ACTIVITY
MODULE 1 - Eosinophils in the esophagus
ACCREDITED ACTIVITY
MODULE 2 - Eosinophils in the stomach and small bowel
ACCREDITED ACTIVITY
MODULE 3 - Eosinophils in the colon

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies